Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2003
11/06/2003US20030207386 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207385 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207383 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207377 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207376 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207371 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207366 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207365 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207364 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207361 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207359 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207357 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207356 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207355 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207354 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207352 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207351 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207350 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207349 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207346 Method for making multispecific antibodies having heteromultimeric and common components
11/06/2003US20030207339 PCAM-1 marker protein, nucleic acid sequences encoding PCAM-1 and immunoassays for detection of PCAM-1
11/06/2003US20030207336 Method of treatment using humanized anti-cd11a antibodies
11/06/2003US20030207335 For preparation of kits and biosensors for disease diagnosis and compound analyses
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207317 Novel nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/06/2003US20030207299 Involves nucleic acid and amino acid sequences of human kinases; used in the diagnosis, treatment, and prevention of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders
11/06/2003US20030207293 Cryptic-like secreted protein
11/06/2003US20030207291 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
11/06/2003US20030207282 Method to amplify variable sequences without imposing primer sequences
11/06/2003US20030207262 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/06/2003US20030207251 For drug screening
11/06/2003US20030207228 Interactive dental restorative network
11/06/2003US20030206924 Equine herpesvirus vaccine
11/06/2003US20030206920 Proteinic product, process for its preparation, compositions containing it and use in medicaments
11/06/2003US20030206911 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target
11/06/2003US20030206909 Antibody that binds to loop 6 of human CXCR4, especially a single chain antibody
11/06/2003US20030206907 Coadministering an antibody specific for one or more of the antigenic determinants characteristic of said vaccine
11/06/2003US20030206905 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
11/06/2003US20030206903 Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/06/2003US20030206902 Administering an antagonist of a vascular endothelial cadherin; and administering an antagonist of a vascular endothelial growth factor receptor.
11/06/2003US20030206900 Vectors derived from antibodies for transferring substances into cells
11/06/2003US20030206899 Vascular endothelial cell growth factor antagonists
11/06/2003US20030206898 Use of anti-TNFalpha antibodies and another drug
11/06/2003US20030206886 Neutralization of immune suppressive factors for the immunotherapy of cancer
11/06/2003US20030206188 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030206187 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003CA2484088A1 Use of pancreatic colipase antagonists to impede weight gain
11/06/2003CA2483980A1 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
11/06/2003CA2483819A1 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003CA2483729A1 Method for treating anxiety and mood disorders in older subjects
11/06/2003CA2483564A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003CA2483551A1 Immunogenic agent therapy using plasmapheresis or exchange transfusion
11/06/2003CA2483475A1 Bispecific molecules for use in therapy and diagnosis of immune related and other diseases
11/06/2003CA2483337A1 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003CA2482996A1 Vitamin d3 upregulated protein 1 treats post-infarct myocardial ischemia
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480291A1 Adipocyte complement related protein zacrp14
11/05/2003EP1359162A2 Mitochondrial creatine kinase antibody
11/05/2003EP1359161A2 Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof
11/05/2003EP1359156A2 Papilloma virus vaccine
11/05/2003EP1358888A1 The human peptide antibiotic LL-37/hCAP-18 is an inducer of angiogenesis
11/05/2003EP1358485A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
11/05/2003EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression
11/05/2003EP1358347A2 Genes expressed in foam cell differentiation
11/05/2003EP1358336A2 Human serine-threonine kinase
11/05/2003EP1358334A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
11/05/2003EP1358330A2 Transporters and ion channels
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358327A2 Proteins and nucleic acids encoding same
11/05/2003EP1358326A2 Proteins associated with cell growth, differentiation, and death
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358318A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1357943A2 Methods and compositions for modulating the immune system of animals
11/05/2003EP1357942A2 Methods and compositions for treatment of immune dysfunction disorders
11/05/2003EP1357941A2 Antagonists of myelin-associated glycoprotein and their use in the treatment and/or prevention of neurological diseases
11/05/2003EP1357930A2 Histidine-rich glycoprotein
11/05/2003EP0938506B1 Immunoglobulin superfamily domains and fragments with increased solubility
11/05/2003EP0602248B1 screening of respiratory diseases throgh measurment of HUMAN LUNG SURFACTANT APOPROTEIN D
11/05/2003EP0601106B2 Morphogen-induced modulation of inflammatory response
11/05/2003EP0489837B1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454216A Antibodies to CCR5
1 ... 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 ... 1494